{"url": "/factchecks/2019/may/22/donald-trump/fact-checking-donald-trumps-claim-drug-prices-are-/", "speaker": "Donald Trump", "vclaim": "Drug prices have been falling for the first time in 51 years because of my administration.", "truth_label": "barely-true", "date": "stated on May 22, 2019 in a speech at the White House:", "title": ":: Verification of Donald Trump &apos; s claim that the prices of medicines are falling", "text": "President Donald Trump reiterated a misleading allegation about the cost of prescription drugs under his supervision. \"The price of drugs is on the decline, for the first time in 51 years because of my administration, but we can make them much less than working with Democrats,\" said Trump on May 22, an address in Rose Park. Trump called a press conference to respond to the comments of the Speaker of the House of Representatives, Nancy Belusi, who accused Trump of reporting to the Congressional Bureau about his administration. We verified a similar statement in April by Mick Mulvani, Acting Chief of Staff of the White House, often mischaracterized. Nothing has changed our conclusion since then. There is a lack of evidence to show that the prices of medicines have fallen after Trump's letter in the Flower Garden. We sent e-mails to the White House Press Office asking whether they have any evidence beyond what we mentioned in our previous report on the verification of facts; we did not get a response. In April, we directed the White House to a 2018 report by its Council of Economic Advisers indicating the efforts of the Trump Administration to reduce prescription costs. Also, the White House sent us data indicating that the price index for the consumption of prescription drugs had declined in January 2019 compared with January 2018. The White House sent data indicating that the cost in January was 11 per cent lower where the trends were that it should have been. However, the most recent data from the Federal Government show a slight rise: the prices of prescription drugs rose by 0.3 per cent in April 2019 compared to April 2018. It is possible to determine the time periods in such a way as to make the statement - or something close to it - accurate with regard to the consumer price index of prescription drugs, as Matthew Fedler, an economist in health at the Brookings Institution, said. However, the CPI is a very incomplete measure to track price trends for prescription drugs, as it measures prices rather than net prices. \"For most purposes, net prices are the most economically relevant amount,\" he said. \"It is unclear how much credit management deserves for these trends.\" Consumer price index data do not explain whether manufacturers that lower their list prices have also changed the size of their discounts. Also, these data do not cover all prescriptions - they only cover medicines sold by retail, or about three quarters of all prescriptions, and they exclude many highly priced specialized medicines that are sold only by mail order. The Department &apos; s proposal that medical care should be paid for medicines administered by doctors on the basis of international average prices could, if implemented, be significantly reduced. However, when - and even if - it will eventually be implemented, it remains an open question. It should also be noted that the Bureau of the Budget of Congress and the Office of Medical Care and Assistance Services of the Actuary have concluded that one of the other proposals of the Department for Marques - the requirement that plans be passed to patients in part D of the Medical Care Programme - would in fact lead to a net increase in the prices of medicines, as Fidler said. This proposal appears to be on track for implementation in 2020 or 2021. On January 14, 2021, Chuck Grasley stated in a tweet that insulin prices had \"lost the RoOOF for patients/taxpayers bc from the manufacturer, a health plan and PBM Biz practices.\" \u2022 February 2, 2012, other drug cost measures do not support Tramp's statement. Data from the Kaiser Foundation for the Family indicate that total spending on the price of prescription drugs has increased over the past several years. \"Caeser Health News, a Puliti Fact partner, is a editorially independent programme of the Foundation.\" In 2018, total spending continued to grow at a slower pace. Experts noted that this trend was positive, but not the same as underexpenditures. :: Benedek Ebluto, economist at the conservative American Enterprise Institute, told Politi Fuckett that it was quite difficult to link Trump management procedures conclusively to large cuts in the prices of medicines - at least not yet, as many of its more consequential proposed reforms had not yet been implemented. Some manufacturers reported that their average net prices had declined in recent years. For example, Janssen, a pharmaceutical company of Johnson & Johnson, reported that net prices fell by 6.8 per cent in 2018. However, many prices for medicines have risen. This year, the price of the list rose to over 3,000 real estate, while the price of only 117 real estates fell, according to data collected by Rx Forced Solutions. Last year, an Associated Press analysis revealed that the prices of branded medicines had increased from January to July, while 46 prices had been reduced. In April, a White House spokesman referred to their efforts to bring more generic medicines to the market. However, experts said that market access for these products, the creation of competition and the demonstration of a significant impact on prices took a long time. In May, Trump urged the Ministry of Health and Human Services to assist the Florida Government. Ron Desantes is a priority in the adoption of a Canadian drug import programme aimed at reducing prices for consumers. No Minister from the Ministry of Health has ever given such approval. It is also unclear whether such an import programme would reduce prices, since drug manufacturers can reduce what they sell to Canadian entities that supply drugs to American wholesalers. Our Governor Trump said, \"The price of drugs is falling, for the first time in 51 years because of my administration.\" There are imaginable data to support the argument that the prices of some of the prescribed medicines list fell in 2018. However, these data do not include many high-priced specialized medicines that drive costs up or up the prices of some individual medicines. At the national level, drug spending continued to rise, even if growth slowed. There is also no evidence to support the argument that Trump himself is responsible for changes in drug pricing. This allegation involves an element of truth, but ignores key facts and contexts that give a very different impression. We value this claim as often false.\" https://www.sharethefacts.co/share/9b9198df-acf6-4251-bb47-690537769cce", "vclaim_id": "vclaim-pol-00603"}